Thailand's military-appointed government will not override a patent on the cancer drug Glivec after Swiss maker Novartis…agreed to supply it free to hundreds of Thai patients… Novartis declined to comment on the deal announced in the final days of the interim government appointed by the military after a 2006 coup…[refers also to Sanofi-Aventis, Merck, and Abbott]